Accès à distance ? S'identifier sur le proxy UCLouvain
Lenalidomide in relapsed refractory myeloma patients: impact of previous response to bortezomib and thalidomide on treatment efficacy. Results of a medical need program in Belgium.
Primary tabs
Document type | Article de périodique (Journal article) – Article de recherche |
---|---|
Publication date | 2011 |
Language | Anglais |
Journal information | "Acta clinica Belgica" - Vol. 66, no.5, p. 371-5 (2011) |
Peer reviewed | yes |
issn | 0001-5512 |
Publication status | Publié |
Affiliations |
UCL
- SSS/IREC/MONT - Pôle Mont Godinne UCL - (MGD) Service d'hématologie |
MESH Subject | Adult ; Female ; Humans ; Male ; Middle Aged ; Multiple Myeloma ; Neoplasm Recurrence, Local ; Pyrazines ; Retrospective Studies ; Survival Analysis ; Thalidomide ; Aged ; Treatment Outcome ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols ; Belgium ; Boronic Acids ; Dexamethasone ; Disease Progression ; Drug Resistance, Neoplasm |
Links |
Bibliographic reference | Delforge, M ; Michiels, A ; Doyen, Chantal ; Kentos, A ; Van Droogenbroeck, J ; et. al. Lenalidomide in relapsed refractory myeloma patients: impact of previous response to bortezomib and thalidomide on treatment efficacy. Results of a medical need program in Belgium.. In: Acta clinica Belgica, Vol. 66, no.5, p. 371-5 (2011) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/123491 |